30 Apr 2009 14:55

Immunodiagnostic Systems Holdings plc
("the Company")
Total Voting Rights
In conformity with the FSA's Disclosure and Transparency Rules, the Company notifies the market of the following:
As at the date of this announcement, the Company's issued share capital consists of 26,440,813 ordinary shares with a nominal value of 2 pence each ("Ordinary Shares"), with voting rights. The Company does not hold any Ordinary Shares in Treasury.
The above figure of 26,440,813 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FSA's Disclosure and Transparency Rules.
For further information:
Immunodiagnostic Systems Holdings plcÂ
Paul Hailes, Finance Director
Tel:Â 0191 519 0660